Sex-specific omics scores of sex hormones and associations with metabolic and sleep disorders

IntroductionSex hormones shape biological sex differences and alter the onset and severity of sleep and metabolic diseases in a sex-specific manner. To better understand relationships and underlying mechanisms, we develop summary proteomics and metabolomics scores for sex hormones and investigate their associations with sleep and metabolic disorders. MethodsWe used proteome-(n= 3680) and metabolome-wide (n= 1649) data from the baseline exam of the Multi-Ethnic Study of Atherosclerosis (MESA) cohort to develop female- and male-specific omics scores for sex hormones including total (Total T), bioavailable (Bio T), and free (Free T) testosterone, estradiol (E2) and sex hormone binding protein (SHBG). Each omics dataset was randomly split assigning 80% of participants to a training dataset and the remaining 20% to a test dataset. We applied linear regression with bootstrap standard errors, adjusting for age, BMI, self-reported race/ethnicity and study site, to identify sex hormone-associated proteins and metabolites (i.e FDR< .05). Lasso penalized regression was then used to select independent features, from which weighted protein (ProtS) and metabolite scores (MetS) were constructed as weighted sums, and examined in the validation dataset. Subsequently, we conducted sex-stratified association analysis of the validated omics scores using data from MESA baseline, exams 4 (proteomics) and 5 (proteomics, metabolomics) with sleep and metabolic phenotypes, timepoints where sex hormones were not measured. ResultsAll constructed omics scores were significantly associated with their corresponding hormones in the test dataset. Higher omics scores of SHBG and lower omics scores of Free T were associated with lower diabetes risk in both sexes; and higher E2 scores with higher incident hypertension risk only in men. In males, Total T had protective diabetes associations, whereas in females they were linked to greater risk. Similarly, higher ProtS-Free T and lower ProtS-SHBG were associated with increased risk for OSA in both sexes. Finally, higher E2 scores were associated with higher risk of insomnia only in males. ConclusionsSummary omics-based scores reveal sex-specific cross-sectional associations with sleep and incident metabolic disorders. These findings highlight the potential of these omics proxies to improve risk stratification and generate insights into mechanisms linking sex hormones with disease.